Bausch Health Companies Inc.

Total Valuation

Bausch Health Companies Inc. carries a market capitalization of 1.85B, placing it among publicly traded companies globally. Its enterprise value stands at 22.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Bausch Health Companies Inc. currently has 373.46M shares outstanding.

Valuation Ratios

Bausch Health Companies Inc. trades at a trailing price-to-earnings ratio of 48.02. The price-to-sales ratio is 0.19, and the price-to-book ratio stands at -3.67.

Enterprise Valuation

On an enterprise value basis, Bausch Health Companies Inc. trades at an EV/EBITDA multiple of 6.18 and an EV/FCF ratio of 5.57. The EV/Sales ratio of 2.14 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.20 provides insight into valuation relative to core operating earnings.

Financial Position

Bausch Health Companies Inc. maintains a current ratio of 1.32, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,921.90, indicating conservative leverage, while an interest coverage ratio of 2.17 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Bausch Health Companies Inc. has paid 285.00M in income taxes, reflecting an effective tax rate of 309.47.

Stock Price Statistics

Bausch Health Companies Inc.'s stock has declined approximately -13.43805% over the past 52 weeks. The 50-day moving average sits at 5.45, while the 200-day moving average is 6.14.

Income Statement

Over the trailing twelve months, Bausch Health Companies Inc. generated 10.53B in revenue and converted that into -1.21B in net income, yielding earnings per share of -3.27. EBITDA reached 3.64B, while operating income came in at 2.44B.

Balance Sheet

Bausch Health Companies Inc. holds 1.30B in cash and equivalents against 20.80B in total debt, resulting in a net debt position of 19.47B. Total book value stands at -548.00M, with working capital of 1.45B providing operational flexibility.

Cash Flow

Bausch Health Companies Inc. produced 1.42B in operating cash flow over the past twelve months. After subtracting -430.00M in capital expenditures, free cash flow totaled 989.00M - equivalent to 2.66 per share.

Margins

Bausch Health Companies Inc. operates with a gross margin of 71.04, reflecting its pricing power and cost economics. The operating margin of 23.20 and net profit margin of -11.47 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Bausch Health Companies Inc.'s most recent stock split took place on October 16, 2000 with a 1:2 split ratio.

Scores

Bausch Health Companies Inc. posts an Altman Z-Score of 0.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.